388 related articles for article (PubMed ID: 16010581)
1. Five-year results of guided tissue regeneration in combination with deproteinized bovine bone (Bio-Oss) in the treatment of intrabony periodontal defects: a case series report.
Stavropoulos A; Karring T
Clin Oral Investig; 2005 Dec; 9(4):271-7. PubMed ID: 16010581
[TBL] [Abstract][Full Text] [Related]
2. Deproteinized bovine bone and gentamicin as an adjunct to GTR in the treatment of intrabony defects: a randomized controlled clinical study.
Stavropoulos A; Karring ES; Kostopoulos L; Karring T
J Clin Periodontol; 2003 Jun; 30(6):486-95. PubMed ID: 12795786
[TBL] [Abstract][Full Text] [Related]
3. GTR treatment of intrabony defects with PLA/PGA copolymer or collagen bioresorbable membranes in combination with deproteinized bovine bone (Bio-Oss).
Stavropoulos A; Sculean A; Karring T
Clin Oral Investig; 2004 Dec; 8(4):226-32. PubMed ID: 15583920
[TBL] [Abstract][Full Text] [Related]
4. Clinical, radiographic, and histologic evaluation of human periodontal defects treated with Bio-Oss and Bio-Gide.
Camelo M; Nevins ML; Schenk RK; Simion M; Rasperini G; Lynch SE; Nevins M
Int J Periodontics Restorative Dent; 1998 Aug; 18(4):321-31. PubMed ID: 12693419
[TBL] [Abstract][Full Text] [Related]
5. A surgical reentry study on the influence of platelet-rich plasma in enhancing the regenerative effects of bovine porous bone mineral and guided tissue regeneration in the treatment of intrabony defects in humans.
Camargo PM; Lekovic V; Weinlaender M; Divnic-Resnik T; Pavlovic M; Kenney EB
J Periodontol; 2009 Jun; 80(6):915-23. PubMed ID: 19485821
[TBL] [Abstract][Full Text] [Related]
6. Combination use of bovine porous bone mineral, enamel matrix proteins, and a bioabsorbable membrane in intrabony periodontal defects in humans.
Lekovic V; Camargo PM; Weinlaender M; Kenney EB; Vasilic N
J Periodontol; 2001 May; 72(5):583-9. PubMed ID: 11394392
[TBL] [Abstract][Full Text] [Related]
7. Platelet-rich plasma and bovine porous bone mineral combined with guided tissue regeneration in the treatment of intrabony defects in humans.
Camargo PM; Lekovic V; Weinlaender M; Vasilic N; Madzarevic M; Kenney EB
J Periodontal Res; 2002 Aug; 37(4):300-6. PubMed ID: 12200975
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of periodontal regeneration following grafting intrabony defects with bio-oss collagen: a human histologic report.
Nevins ML; Camelo M; Lynch SE; Schenk RK; Nevins M
Int J Periodontics Restorative Dent; 2003 Feb; 23(1):9-17. PubMed ID: 12617364
[TBL] [Abstract][Full Text] [Related]
9. Guided tissue regeneration combined with a deproteinized bovine bone mineral (Bio-Oss) in the treatment of intrabony periodontal defects: 6-year results from a randomized-controlled clinical trial.
Stavropoulos A; Karring T
J Clin Periodontol; 2010 Feb; 37(2):200-10. PubMed ID: 20653820
[TBL] [Abstract][Full Text] [Related]
10. GTR therapy of intrabony defects using 2 different bioresorbable membranes: 12-month results.
Christgau M; Bader N; Schmalz G; Hiller KA; Wenzel A
J Clin Periodontol; 1998 Jun; 25(6):499-509. PubMed ID: 9667484
[TBL] [Abstract][Full Text] [Related]
11. Healing of human intrabony defects following regenerative periodontal therapy with a bovine-derived xenograft and guided tissue regeneration.
Sculean A; Stavropoulos A; Windisch P; Keglevich T; Karring T; Gera I
Clin Oral Investig; 2004 Jun; 8(2):70-4. PubMed ID: 14767696
[TBL] [Abstract][Full Text] [Related]
12. Comparison of platelet-rich plasma, bovine porous bone mineral, and guided tissue regeneration versus platelet-rich plasma and bovine porous bone mineral in the treatment of intrabony defects: a reentry study.
Lekovic V; Camargo PM; Weinlaender M; Vasilic N; Kenney EB
J Periodontol; 2002 Feb; 73(2):198-205. PubMed ID: 11895286
[TBL] [Abstract][Full Text] [Related]
13. Five-year results of a prospective, randomized, controlled study evaluating treatment of intra-bony defects with a natural bone mineral and GTR.
Sculean A; Schwarz F; Chiantella GC; Donos N; Arweiler NB; Brecx M; Becker J
J Clin Periodontol; 2007 Jan; 34(1):72-7. PubMed ID: 17243997
[TBL] [Abstract][Full Text] [Related]
14. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 5-year clinical and radiological study.
Mengel R; Schreiber D; Flores-de-Jacoby L
J Periodontol; 2006 Oct; 77(10):1781-7. PubMed ID: 17032123
[TBL] [Abstract][Full Text] [Related]
15. Clinical and radiographic treatment evaluation of class III furcation defects using GTR with and without inorganic bone matrix.
Palioto DB; Joly JC; de Lima AF; Mota LF; Caffesse R
J Clin Periodontol; 2003 Jan; 30(1):1-8. PubMed ID: 12702104
[TBL] [Abstract][Full Text] [Related]
16. A comparative study on the use of Bio-Oss and enamel matrix derivative (Emdogain) in the treatment of periodontal bone defects.
Pietruska MD
Eur J Oral Sci; 2001 Jun; 109(3):178-81. PubMed ID: 11456348
[TBL] [Abstract][Full Text] [Related]
17. A comparative study on the use of a HA/collagen/chondroitin sulphate biomaterial (Biostite) and a bovine-derived HA xenograft (Bio-Oss) in the treatment of deep intra-osseous defects.
Scabbia A; Trombelli L
J Clin Periodontol; 2004 May; 31(5):348-55. PubMed ID: 15086616
[TBL] [Abstract][Full Text] [Related]
18. Treatment of intrabony defects with anorganic bone matrix/p-15 or guided tissue regeneration in patients with aggressive periodontitis.
Queiroz AC; Nóbrega PB; Oliveira FS; Novaes AB; Taba M; Palioto DB; Grisi MF; Souza SL
Braz Dent J; 2013; 24(3):204-12. PubMed ID: 23969907
[TBL] [Abstract][Full Text] [Related]
19. Use of bovine-derived anorganic bone associated with guided tissue regeneration in intrabony defects. Six-month evaluation at re-entry.
Batista EL; Novaes AB; Simonpietri JJ; Batista FC
J Periodontol; 1999 Sep; 70(9):1000-7. PubMed ID: 10505802
[TBL] [Abstract][Full Text] [Related]
20. Reconstruction of anatomically complicated periodontal defects using a bioresorbable GTR barrier supported by bone mineral. A 6-month follow-up study of 6 cases.
Lundgren D; Slotte C
J Clin Periodontol; 1999 Jan; 26(1):56-62. PubMed ID: 9923512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
